SLC2A4 and Disorder of energy metabolism: Further, graphene-FIR therapy activated the thermogenic program in adipose tissue, increasing the expression of UCP1 and glucose transporter protein four (GLUT4), activating the AMPK/PGC-1α/SIRT1 pathway in iWAT and BAT, and improving energy metabolism disorder in HFD mice.